Copyright Reports & Markets. All rights reserved.

Global Tissue Diagnostic Market 2019 by Company, Regions, Type and Application, Forecast to 2024

Buy now

Table of Contents

    1 Tissue Diagnostic Market Overview

    • 1.1 Product Overview and Scope of Tissue Diagnostic
    • 1.2 Classification of Tissue Diagnostic by Type
      • 1.2.1 Global Tissue Diagnostic Revenue by Type: 2015 VS 2019 VS 2025
      • 1.2.2 Global Tissue Diagnostic Revenue Market Share by Type in 2019
      • 1.2.3 Immuno Histochemistry
      • 1.2.4 In-Situ Hybridization
      • 1.2.5 Digital Pathology
      • 1.2.6 Special Staining
    • 1.3 Global Tissue Diagnostic Market by Application
      • 1.3.1 Overview: Global Tissue Diagnostic Revenue by Application: 2015 VS 2019 VS 2025
      • 1.3.2 Hospitals
      • 1.3.3 Ambulatory Surgical Centers
      • 1.3.4 Diagnostic Centers
      • 1.3.5 Research Laboratories
    • 1.4 Global Tissue Diagnostic Market by Regions
      • 1.4.1 Global Tissue Diagnostic Market Size by Regions: 2015 VS 2019 VS 2025
      • 1.4.2 Global Market Size of Tissue Diagnostic (2015-2025)
      • 1.4.3 North America (USA, Canada and Mexico) Tissue Diagnostic Status and Prospect (2015-2025)
      • 1.4.4 Europe (Germany, France, UK, Russia and Italy) Tissue Diagnostic Status and Prospect (2015-2025)
      • 1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Tissue Diagnostic Status and Prospect (2015-2025)
      • 1.4.6 South America (Brazil, Argentina, Colombia) Tissue Diagnostic Status and Prospect (2015-2025)
      • 1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Tissue Diagnostic Status and Prospect (2015-2025)

    2 Company Profiles

    • 2.1 Abbott Laboratories
      • 2.1.1 Abbott Laboratories Details
      • 2.1.2 Abbott Laboratories Major Business and Total Revenue (Financial Highlights) Analysis
      • 2.1.3 Abbott Laboratories SWOT Analysis
      • 2.1.4 Abbott Laboratories Product and Services
      • 2.1.5 Abbott Laboratories Tissue Diagnostic Revenue, Gross Margin and Market Share (2018-2019)
    • 2.2 Sigma-Aldrich Corporation
      • 2.2.1 Sigma-Aldrich Corporation Details
      • 2.2.2 Sigma-Aldrich Corporation Major Business and Total Revenue (Financial Highlights) Analysis
      • 2.2.3 Sigma-Aldrich Corporation SWOT Analysis
      • 2.2.4 Sigma-Aldrich Corporation Product and Services
      • 2.2.5 Sigma-Aldrich Corporation Tissue Diagnostic Revenue, Gross Margin and Market Share (2018-2019)
    • 2.3 Cell Signaling Technology
      • 2.3.1 Cell Signaling Technology Details
      • 2.3.2 Cell Signaling Technology Major Business and Total Revenue (Financial Highlights) Analysis
      • 2.3.3 Cell Signaling Technology SWOT Analysis
      • 2.3.4 Cell Signaling Technology Product and Services
      • 2.3.5 Cell Signaling Technology Tissue Diagnostic Revenue, Gross Margin and Market Share (2018-2019)
    • 2.4 Agilent Technologies
      • 2.4.1 Agilent Technologies Details
      • 2.4.2 Agilent Technologies Major Business and Total Revenue (Financial Highlights) Analysis
      • 2.4.3 Agilent Technologies SWOT Analysis
      • 2.4.4 Agilent Technologies Product and Services
      • 2.4.5 Agilent Technologies Tissue Diagnostic Revenue, Gross Margin and Market Share (2018-2019)
    • 2.5 Sakura Finetek Japan Co., Ltd.
      • 2.5.1 Sakura Finetek Japan Co., Ltd. Details
      • 2.5.2 Sakura Finetek Japan Co., Ltd. Major Business and Total Revenue (Financial Highlights) Analysis
      • 2.5.3 Sakura Finetek Japan Co., Ltd. SWOT Analysis
      • 2.5.4 Sakura Finetek Japan Co., Ltd. Product and Services
      • 2.5.5 Sakura Finetek Japan Co., Ltd. Tissue Diagnostic Revenue, Gross Margin and Market Share (2018-2019)
    • 2.6 Biogenex Laboratories
      • 2.6.1 Biogenex Laboratories Details
      • 2.6.2 Biogenex Laboratories Major Business and Total Revenue (Financial Highlights) Analysis
      • 2.6.3 Biogenex Laboratories SWOT Analysis
      • 2.6.4 Biogenex Laboratories Product and Services
      • 2.6.5 Biogenex Laboratories Tissue Diagnostic Revenue, Gross Margin and Market Share (2018-2019)
    • 2.7 GE Healthcare
      • 2.7.1 GE Healthcare Details
      • 2.7.2 GE Healthcare Major Business and Total Revenue (Financial Highlights) Analysis
      • 2.7.3 GE Healthcare SWOT Analysis
      • 2.7.4 GE Healthcare Product and Services
      • 2.7.5 GE Healthcare Tissue Diagnostic Revenue, Gross Margin and Market Share (2018-2019)
    • 2.8 F. Hoffman-La Roche AG
      • 2.8.1 F. Hoffman-La Roche AG Details
      • 2.8.2 F. Hoffman-La Roche AG Major Business and Total Revenue (Financial Highlights) Analysis
      • 2.8.3 F. Hoffman-La Roche AG SWOT Analysis
      • 2.8.4 F. Hoffman-La Roche AG Product and Services
      • 2.8.5 F. Hoffman-La Roche AG Tissue Diagnostic Revenue, Gross Margin and Market Share (2018-2019)
    • 2.9 Danaher Corporation
      • 2.9.1 Danaher Corporation Details
      • 2.9.2 Danaher Corporation Major Business and Total Revenue (Financial Highlights) Analysis
      • 2.9.3 Danaher Corporation SWOT Analysis
      • 2.9.4 Danaher Corporation Product and Services
      • 2.9.5 Danaher Corporation Tissue Diagnostic Revenue, Gross Margin and Market Share (2018-2019)
    • 2.10 Roche Diagnostics
      • 2.10.1 Roche Diagnostics Details
      • 2.10.2 Roche Diagnostics Major Business and Total Revenue (Financial Highlights) Analysis
      • 2.10.3 Roche Diagnostics SWOT Analysis
      • 2.10.4 Roche Diagnostics Product and Services
      • 2.10.5 Roche Diagnostics Tissue Diagnostic Revenue, Gross Margin and Market Share (2018-2019)

    3 Market Competition, by Players

    • 3.1 Global Tissue Diagnostic Revenue and Share by Players (2015-2020)
    • 3.2 Market Concentration Rate
      • 3.2.1 Top 5 Tissue Diagnostic Players Market Share
      • 3.2.2 Top 10 Tissue Diagnostic Players Market Share
    • 3.3 Market Competition Trend

    4 Market Size by Regions

    • 4.1 Global Tissue Diagnostic Revenue and Market Share by Regions
    • 4.2 North America Tissue Diagnostic Revenue and Growth Rate (2015-2020)
    • 4.3 Europe Tissue Diagnostic Revenue and Growth Rate (2015-2020)
    • 4.4 Asia-Pacific Tissue Diagnostic Revenue and Growth Rate (2015-2020)
    • 4.5 South America Tissue Diagnostic Revenue and Growth Rate (2015-2020)
    • 4.6 Middle East & Africa Tissue Diagnostic Revenue and Growth Rate (2015-2020)

    5 North America Tissue Diagnostic Revenue by Countries

    • 5.1 North America Tissue Diagnostic Revenue by Countries (2015-2020)
    • 5.2 USA Tissue Diagnostic Revenue and Growth Rate (2015-2020)
    • 5.3 Canada Tissue Diagnostic Revenue and Growth Rate (2015-2020)
    • 5.4 Mexico Tissue Diagnostic Revenue and Growth Rate (2015-2020)

    6 Europe Tissue Diagnostic Revenue by Countries

    • 6.1 Europe Tissue Diagnostic Revenue by Countries (2015-2020)
    • 6.2 Germany Tissue Diagnostic Revenue and Growth Rate (2015-2020)
    • 6.3 UK Tissue Diagnostic Revenue and Growth Rate (2015-2020)
    • 6.4 France Tissue Diagnostic Revenue and Growth Rate (2015-2020)
    • 6.5 Russia Tissue Diagnostic Revenue and Growth Rate (2015-2020)
    • 6.6 Italy Tissue Diagnostic Revenue and Growth Rate (2015-2020)

    7 Asia-Pacific Tissue Diagnostic Revenue by Countries

    • 7.1 Asia-Pacific Tissue Diagnostic Revenue by Countries (2015-2020)
    • 7.2 China Tissue Diagnostic Revenue and Growth Rate (2015-2020)
    • 7.3 Japan Tissue Diagnostic Revenue and Growth Rate (2015-2020)
    • 7.4 Korea Tissue Diagnostic Revenue and Growth Rate (2015-2020)
    • 7.5 India Tissue Diagnostic Revenue and Growth Rate (2015-2020)
    • 7.6 Southeast Asia Tissue Diagnostic Revenue and Growth Rate (2015-2020)

    8 South America Tissue Diagnostic Revenue by Countries

    • 8.1 South America Tissue Diagnostic Revenue by Countries (2015-2020)
    • 8.2 Brazil Tissue Diagnostic Revenue and Growth Rate (2015-2020)
    • 8.3 Argentina Tissue Diagnostic Revenue and Growth Rate (2015-2020)

    9 Middle East & Africa Revenue Tissue Diagnostic by Countries

    • 9.1 Middle East & Africa Tissue Diagnostic Revenue by Countries (2015-2020)
    • 9.2 Saudi Arabia Tissue Diagnostic Revenue and Growth Rate (2015-2020)
    • 9.3 UAE Tissue Diagnostic Revenue and Growth Rate (2015-2020)
    • 9.4 Egypt Tissue Diagnostic Revenue and Growth Rate (2015-2020)
    • 9.5 South Africa Tissue Diagnostic Revenue and Growth Rate (2015-2020)

    10 Market Size Segment by Type

    • 10.1 Global Tissue Diagnostic Revenue and Market Share by Type (2015-2020)
    • 10.2 Global Tissue Diagnostic Market Forecast by Type (2019-2024)
    • 10.3 Immuno Histochemistry Revenue Growth Rate (2015-2025)
    • 10.4 In-Situ Hybridization Revenue Growth Rate (2015-2025)
    • 10.5 Digital Pathology Revenue Growth Rate (2015-2025)
    • 10.6 Special Staining Revenue Growth Rate (2015-2025)

    11 Global Tissue Diagnostic Market Segment by Application

    • 11.1 Global Tissue Diagnostic Revenue Market Share by Application (2015-2020)
    • 11.2 Tissue Diagnostic Market Forecast by Application (2019-2024)
    • 11.3 Hospitals Revenue Growth (2015-2020)
    • 11.4 Ambulatory Surgical Centers Revenue Growth (2015-2020)
    • 11.5 Diagnostic Centers Revenue Growth (2015-2020)
    • 11.6 Research Laboratories Revenue Growth (2015-2020)

    12 Global Tissue Diagnostic Market Size Forecast (2021-2025)

    • 12.1 Global Tissue Diagnostic Market Size Forecast (2021-2025)
    • 12.2 Global Tissue Diagnostic Market Forecast by Regions (2021-2025)
    • 12.3 North America Tissue Diagnostic Revenue Market Forecast (2021-2025)
    • 12.4 Europe Tissue Diagnostic Revenue Market Forecast (2021-2025)
    • 12.5 Asia-Pacific Tissue Diagnostic Revenue Market Forecast (2021-2025)
    • 12.6 South America Tissue Diagnostic Revenue Market Forecast (2021-2025)
    • 12.7 Middle East & Africa Tissue Diagnostic Revenue Market Forecast (2021-2025)

    13 Research Findings and Conclusion

      14 Appendix

      • 14.1 Methodology
      • 14.2 Data Source
      • 14.3 Disclaimer

      Market Overview
      The global Tissue Diagnostic market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 5.2% in the forecast period of 2020 to 2025 and will expected to reach USD 5208.6 million by 2025, from USD 4260 million in 2019.

      The Tissue Diagnostic market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

      Market segmentation
      Tissue Diagnostic market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

      By Type, Tissue Diagnostic market has been segmented into:
      Immuno Histochemistry
      In-Situ Hybridization
      Digital Pathology
      Special Staining

      By Application, Tissue Diagnostic has been segmented into:
      Hospitals
      Ambulatory Surgical Centers
      Diagnostic Centers
      Research Laboratories

      Regions and Countries Level Analysis
      Regional analysis is another highly comprehensive part of the research and analysis study of the global Tissue Diagnostic market presented in the report. This section sheds light on the sales growth of different regional and country-level Tissue Diagnostic markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Tissue Diagnostic market.

      The report offers in-depth assessment of the growth and other aspects of the Tissue Diagnostic market in important countries (regions), including:
      North America (United States, Canada and Mexico)
      Europe (Germany, France, UK, Russia and Italy)
      Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
      South America (Brazil, Argentina, Colombia)
      Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

      Competitive Landscape and Tissue Diagnostic Market Share Analysis
      Tissue Diagnostic competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Tissue Diagnostic sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Tissue Diagnostic sales, revenue and market share for each player covered in this report.

      The major players covered in Tissue Diagnostic are:
      Abbott Laboratories
      Sigma-Aldrich Corporation
      Cell Signaling Technology
      Agilent Technologies
      Sakura Finetek Japan Co., Ltd.
      Biogenex Laboratories
      GE Healthcare
      F. Hoffman-La Roche AG
      Danaher Corporation
      Roche Diagnostics

      Buy now